Trademark: 87511079
Status Date
Tuesday, February 12, 2019
Registration Number
5672248
Registration Date
Tuesday, February 12, 2019
Filing Date
Thursday, June 29, 2017
Published for Opposition
Tuesday, November 27, 2018
5 Pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies containing neridronic acid and/or its salts thereof; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies, namely, neridronic acid and/or its salts thereof; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies containing neridronate sodium; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies, namely, neridronate sodium
Feb 12, 2024
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Feb 12, 2019
Registered-Principal Register
Nov 27, 2018
Official Gazette Publication Confirmation E-Mailed
Nov 27, 2018
Published For Opposition
Nov 7, 2018
Notification Of Notice Of Publication E-Mailed
Oct 23, 2018
Approved For Pub - Principal Register
Oct 23, 2018
Teas/Email Correspondence Entered
Oct 23, 2018
Correspondence Received In Law Office
Oct 17, 2018
Assigned To Lie
Oct 8, 2018
Teas Response To Suspension Inquiry Received
Oct 8, 2018
Teas Change Of Correspondence Received
Apr 9, 2018
Notification Of Inquiry As To Suspension E-Mailed
Apr 9, 2018
Inquiry To Suspension E-Mailed
Apr 9, 2018
Suspension Inquiry Written
Oct 9, 2017
Notification Of Letter Of Suspension E-Mailed
Oct 9, 2017
Letter Of Suspension E-Mailed
Oct 9, 2017
Suspension Letter Written
Sep 26, 2017
Assigned To Examiner
Jul 8, 2017
New Application Office Supplied Data Entered
Jul 3, 2017
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
